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It is always difficult to produce a book concerning a rapidly
advancing field of science that is not out of date by the time
it is published. Drug resistance is such a field. Since the
various chapters in this book were written many papers have
appeared which give, for example, a much better perspective
regarding the significance of P-glycoprotein mediated multi-
drug resistance in clinical cancers and the distribution of
glutathione-S-transferase iso-enzymes in human tumours. It
is, in fact, quite difficult to determine when the bulk of the
material was written. Some of the chapters contain few or no
1987 references in their reference lists, while others contain
the odd 1988 reference. For example, reference 59 in the
chapter by Harris and Hickson, given as 'in press', was
published in the British Journal of Cancer in January 1987,
and reference 52 in the chapter by Tritton and Posada (the
author of which reference is D. Kessel!) is given as Cancer
Surveys, in press, 1986. The reader needs to be aware of this
heterogeneity when judging just how up to date the inform-
ation really is.
The book contains a total of 22 chapters. Whereas some of
the individual chapters deal with resistance to specific
cytotoxic drugs (or closely related group of drugs), others are
addressed towards more general mechanisms of resistance or
related topics. This is not necessarily a bad thing but
inevitably leads to considerable overlap. It is difficult, for
example, to see the need for three chapters dealing with
'Tumour cell resistance to etopside - a review' (Chapter 11,
by B. Hill and R.B. Lock), 'Resistance to teniposide and
etoposide' (Chapter 12, by D. Roberts) and 'Toposisomerase
II mediated mechanisms of drug resistance' (Chapter 16, by
D.M. Sullivan, K.C. Chow and W.E. Ross). On the other
hand, it is refreshing to see less fashionable topics, such as
'Drug-resistance to cytosine arabinoside' (Chapter 19, by
R. Momparler and N. Onetto-Pothier) and 'Glucocorticoid
resistance in leukemic cells' (Chapter 21, by J.M. Harmon
and E.B. Thompson) given a comprehensive airing. Surely,
however, if there was felt to be room for a chapter on
'Resistance to bleomycin-group antibiotics' (Chapter 15, by
J. Lazo and S.M. Sebti) there should have been room for a
chapter on resistance to cisplatin and its analogues.
I found the most readable chapter to be that by Abraham
Goldin in which he reviews the historical aspects of tumour
resistance to chemotherapy. Relative newcomers to the field
may be surprised to learn that effects of various compounds
in sensitive and resistant sublines of leukaemia L1210 were
studied by Skipper and Thomson in 1955! Almost all of the
chapters are well written and well referenced, as would be
expected from the list of contributors. The extent to which
individual authors have attempted to put data from their
own laboratories in the wider context is, however, extremely
variable. It would be interesting to know what instructions
were given by the editor in this regard.
The presentation of the volume, including binding and
quality of paper, is extremely good. For a book priced at the
astronomical sum of £132.50 it would be appalling if this
were not so. I found very few typographical errors and the
indexing is extremely comprehensive. Surely, however, the
referencing system used should not vary from chapter to
chapter as it does.
My personal feeling is that this book rather falls between
two stools. For background reading, I would prefer to see a
single-author volume in which a comprehensive and consis-
tent overview (albeit, of necessity, a personalised one) of the
topic were presented. On the other hand a rapidly produced
volume containing very up-to-date contributions from a
topic-oriented conference would be more valuable to active
workers in the field. The present book will, however,
undoubtedly be a useful library volume for background in-
formation, particularly on the less-fashionable aspects of
drug resistance.
It is hoped that, in the relatively near future, there will be
books on drug resistance which are meant as handbooks for
clinicians, telling them for instance how best to determine
P-glycoprotein content of tumours and how to choose the
optimal resistance modifying agent. On the other hand, it is
not impossible that the next book will contain chapters on
resistance to verapamil and ethacrynic acid.
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